Last reviewed · How we verify

NCT06331416

Multiparametric Home Telemonitoring of Patients With Chronic Obstructive Pulmonary Disease Exacerbation

Recruiting now NA Last updated 2 May 2024
What this trial tests

NA trial testing Telemonitoring in COPD in 60 participants. Currently enrolling.

Timeline
29 March 2024
Primary endpoint
1 April 2026
30 September 2026

Quick facts

Lead sponsorUniversity of Trieste
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment60
Start date29 March 2024
Primary completion1 April 2026
Estimated completion30 September 2026
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

University of Trieste

Who can join

Adults 18 to 90, any sex, with COPD or COPD Exacerbation Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Chronic obstructive pulmonary disease (COPD) exacerbations are risk factors for disease progression and short-term re- hospitalizations. We propose a randomized controlled trial to evaluate the efficacy of a one-device multiparameter telemonitoring in reducing functional decline, symptoms, and risk of re-hospitalization of patients discharged after hospitalization for exacerbated COPD.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Telemonitoring

Trials testing the same drug.

Other recruiting trials for COPD

Currently open trials in the same condition.

Other University of Trieste trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06331416.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing